John M. Klopp
Chief Tech/Sci/R&D Officer chez ACER THERAPEUTICS INC.
Profil
John M.
Klopp is currently the Chief Technical Officer at Acer Therapeutics, Inc. Prior to this, he worked as the Senior Director-Manufacturing Management at Ultragenyx Pharmaceutical, Inc. from 2013 to 2018.
Mr. Klopp received his undergraduate degree from The Pennsylvania State University and his graduate degree from the University of California, Berkeley.
Postes actifs de John M. Klopp
| Sociétés | Poste | Début |
|---|---|---|
| ACER THERAPEUTICS INC. | Chief Tech/Sci/R&D Officer | 01/09/2019 |
Anciens postes connus de John M. Klopp
| Sociétés | Poste | Fin |
|---|---|---|
| ULTRAGENYX PHARMACEUTICAL INC. | Corporate Officer/Principal | 01/01/2018 |
Formation de John M. Klopp
| The Pennsylvania State University | Undergraduate Degree |
| University of California, Berkeley | Graduate Degree |
Expériences
Fonctions occupées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Sociétés cotées | 1 |
|---|---|
| ULTRAGENYX PHARMACEUTICAL INC. | Health Technology |
| Entreprise privées | 1 |
|---|---|
Acer Therapeutics, Inc.
 Acer Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Acer Therapeutics, Inc. is a pharmaceutical company, which engages in the acquisition, development, and commercialization of therapies for medical needs. Its product pipeline includes Olpruva, Edsivo, and ACER-801. Olpruva is used for the treatment of urea cycle disorders. Edsivo is a type of celiprolol used in treating Vascular Ehlers-Danlos syndrome. ACER-001 treats menopausal related Vasomotor symptoms. The company was founded by Chris Schelling on March 15, 1991 and is headquartered in Newton, MA. | Health Technology |
